Global advanced infusion systems market is growing at a significant CAGR due to the increasing global prevalence of chronic diseases. An increase in prevalence and incidence of chronic diseases such as cancer, diabetes etc. is the key factor drives the global advanced infusion systems market growth. In addition, technological developments in advanced infusion systems which reduce the risks, increase in safety, bioavailability, and therapeutic effectiveness of drugs, and an increasing healthcare expenditure are the factors expected to fuel the global advanced infusion systems market over the forecast period. Similarly, increasing use of advanced infusion products in home care owing to favourable reimbursements, visual monitoring, mobility of the system, continues infusion for multiple medications at the same time, and patient safety are few factors fuel the advanced infusion systems market over the forecast period. However, lack of awareness in using advanced infusion systems expected to hinder the growth of global advanced infusion systems market. Apart from this, product recalls, possible medication errors associated with an infusion pump, and strict regulations for product approval are also some key factors might hamper the growth of global advanced infusion systems market over the forecast period.


A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-advanced-infusion-systems-market/#ulp-4H8Z4LpNMLEuOnnx

The advanced infusion systems market has been segmented based on the product type, pumping channel, application, and end user

Based on product type, advanced infusion systems market is segmented into the following:
Elastomeric infusion systems
Volumetric infusion systems
Large volume
Small volume pump
Disposable infusion systems
Patient controlled analgesia pumps
Syringe infusion systems
Ambulatory infusion systems
Implantable infusion systems

Based on pumping channel, advanced infusion systems market is segmented into the following:
Single Channel Infusion Pumps
Multiple Channel Infusion Pumps

Based on the application, advanced infusion systems market is segmented into the following:
Diabetes
Asthma
Chemotherapy
Pain management
Clinical nutrition
Others

Based on the end-user, advanced infusion systems market is segmented into the following:
Hospitals
Clinics
Home care
Ambulatory Surgical Centres
Others

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-advanced-infusion-systems-market/#ulp-c654SbFYO64MsOhu

Global advanced infusion systems market is in developing stage, several local and international players are actively involved in the development and marketing of advanced infusion systems. In 2015, the volumetric infusion pumps dominated the global advanced infusion systems market due to the increasing demand for volumetric infusion pumps in hospitals, long-term acute care centres, clinics, and ambulatory surgery centres. Rising incidence rate of chronic disorders such as diabetes, cancer and increase in geriatric population are drive the growth of advanced infusion systems market over the forecast period. Rising malnutrition around the globe is expected boost the demand for infusion pumps for clinical nutrition. Technological advancements are playing a major role in the growth of the global advanced infusion systems market. Players in the market are focusing on developing innovative products to gain a competitive edge. For instance, in 2013, Terumo launched the Terufusion advanced infusion system, the latest generation of infusion and syringe pumps, which is convenient handling for multiple infusions.

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-advanced-infusion-systems-market/#ulp-14mlyhjMGhVjZqa3

Geographically, global advanced infusion systems market has been segmented into following regions Viz. North America, Asia-Pacific, Europe, Middle East & Africa, and Latin America,. North America commands significant share in the global advanced infusion systems market followed by Europe and Asia-Pacific. The largest share of North-America in global advanced infusion systems market is due to high adoption of ambulatory pumps in the management of chronic diseases, high prevalence chronic diseases like cancer (according to American National Cancer Institute, In 2016, an estimated 1,685,210 new cases of cancer will be diagnosed in the United States) and well-established healthcare infrastructure in the region. Europe is the second largest region in the global advanced infusion systems market owing to increasing the prevalence of cancer disease (according to world cancer research fund international, In 2012, globally Denmark is the top country in the prevalence rate of cancer with 338 per 100,000 people and increasing significantly every year). Asia-Pacific region, particularly China and India, are expected to present substantial growth opportunities for advanced infusion systems market players over the forecast period which is mainly attributed to the huge patient population, increasing the incidence of chronic diseases with changing lifestyles, improving healthcare facilities, increasing accessibility to advanced products, and rising disposable income.

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-advanced-infusion-systems-market/


Some of the players in global advanced infusion systems market are Hospira, Inc. (Pfizer Inc.) (U.S.), AngioDynamics (U.S.), Becton, Dickinson and Company (U.S.), Animas Corporation (Johnson & Johnson) (U.S.), B. Braun Melsungen AG (Germany), Terumo Medical Corporation (Japan), Iartic Systems Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic (U.S.), Baxter International Inc. (U.S.), and I-Flow Corporation (Kimberly-Clark) (U.S.) to name a few.


"Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX

Email: [email protected]
Toll Free(US): +1-866-598-1553"